Avoro Capital Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
33
Total Value
6406567714
Accession Number
0001104659-25-048904
Form Type
13F-HR
Manager Name
Avoro Capital Advisors LLC
Data Enrichment
97% identified
32 identified1 unidentified

Holdings

33 positions
Manager:
Search and click to pin securities to the top
Page 1 of 2
UNITED THERAPEUTICS Corp
Shares:
2675000(-3.1%)
Value:
$824.6B(-15.3%)
Ascendis Pharma A/S
Shares:
5218000(+2.3%)
Value:
$813.3B(+15.8%)
ARGENX SE
Shares:
1235177(-0.3%)
Value:
$731.1B(-4.0%)
MADRIGAL PHARMACEUTICALS, INC.
Shares:
2022222(-0.3%)
Value:
$669.8B(+7.0%)
Krystal Biotech, Inc.
Shares:
2731000(+3.9%)
Value:
$492.4B(+19.6%)
Blueprint Medicines Corp
Shares:
3850000(+224.9%)
Value:
$340.8B(+229.7%)
Apellis Pharmaceuticals, Inc.
Shares:
12222222(+0.0%)
Value:
$267.3B(-31.5%)
Avidity Biosciences, Inc.
Shares:
7625000(+1.7%)
Value:
$225.1B(+3.2%)
Xenon Pharmaceuticals Inc.
Shares:
5741666(+1.3%)
Value:
$192.6B(-13.3%)
SOLENO THERAPEUTICS INC
Shares:
2525000(+0.0%)
Value:
$180.4B(+59.0%)
Kymera Therapeutics, Inc.
Shares:
6460000(+25.4%)
Value:
$176.8B(-14.7%)
Sarepta Therapeutics, Inc.
Shares:
2674835(+4.7%)
Value:
$170.7B(-45.1%)
AMICUS THERAPEUTICS, INC.
Shares:
20500000(-11.5%)
Value:
$167.3B(-23.4%)
ARROWHEAD PHARMACEUTICALS, INC.
Shares:
11111111(+0.0%)
Value:
$141.6B(-32.2%)
Vera Therapeutics, Inc.
Shares:
5701900(+1.6%)
Value:
$137.0B(-42.3%)
Merus N.V.
Shares:
3000000(+41.2%)
Value:
$126.3B(+41.3%)
MoonLake Immunotherapeutics
Shares:
2770100(+0.0%)
Value:
$108.2B(-27.8%)
46116X101
Shares:
625000(-79.5%)
Value:
$82.5B(-67.6%)
Alkermes plc.
Shares:
2450000(+0.0%)
Value:
$80.9B(+14.8%)
BIOCRYST PHARMACEUTICALS INC
Shares:
8700000(-26.7%)
Value:
$65.3B(-26.9%)